Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, today announced that members of ...

One of the most useful tools that the Crystal Ball employs on a regular basis is Dave’s Redistricting App, which helps us make sense of redistricting and includes a plethora of data.— Using some of ...

Expect to share initial clinical and translational data from the Phase 1 trial of LYL797, a ROR1-targeted CAR T‑cell product candidate, this quarter On track to report initial clinical data from the ...

Furthermore, it said the growing availability of e-cigarette products is expected to gradually erose the market share of traditional cigarettes, which will affect BAT's sales. In a filing with ...